Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Tolboom JTBM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Solforosi L; Janssen Vaccines and Prevention B.V., Leiden, Netherlands. lsolforo@its.jnj.com., Costes LMM; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Tolboom JTBM; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., McMahan K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Anioke T; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Hope D; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Murdza T; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Sciacca M; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Bouffard E; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Barrett J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Wu C; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Hachmann N; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Miller J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Yu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., He X; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Jacob-Dolan C; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Huber SKR; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Dekking L; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Chamanza R; Non-Clinical Safety Toxicology/Pathology, Janssen Research and Development, Beerse, Belgium., Choi Y; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Boer KF; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA., Schuitemaker H; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Zahn RC; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Wegmann F; Janssen Vaccines and Prevention B.V., Leiden, Netherlands. fwegmann@its.jnj.com.
Publikováno v:
Nature communications [Nat Commun] 2023 Apr 07; Vol. 14 (1), pp. 1944. Date of Electronic Publication: 2023 Apr 07.
Autor:
Tostanoski LH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Chandrashekar A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Patel S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Yu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Jacob-Dolan C; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Chang A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Powers OC; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Sellers D; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Gardner S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Barrett J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Sanborn O; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Stephenson KE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Ansel JL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Jaegle K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Porto M; BIOQUAL, Inc., Rockville, MD, USA., Lok M; BIOQUAL, Inc., Rockville, MD, USA., Spence B; BIOQUAL, Inc., Rockville, MD, USA., Cayer K; BIOQUAL, Inc., Rockville, MD, USA., Nase D; BIOQUAL, Inc., Rockville, MD, USA., Holman S; BIOQUAL, Inc., Rockville, MD, USA., Bradette H; BIOQUAL, Inc., Rockville, MD, USA., Kar S; BIOQUAL, Inc., Rockville, MD, USA., Andersen H; BIOQUAL, Inc., Rockville, MD, USA., Lewis MG; BIOQUAL, Inc., Rockville, MD, USA., Cox F; Janssen Vaccines & Prevention, Leiden, The Netherlands., Tolboom JTBM; Janssen Vaccines & Prevention, Leiden, The Netherlands., de Groot AM; Janssen Vaccines & Prevention, Leiden, The Netherlands., Heerwegh D; Janssen Research & Development, Beerse, Belgium., Le Gars M; Janssen Vaccines & Prevention, Leiden, The Netherlands., Sadoff J; Janssen Vaccines & Prevention, Leiden, The Netherlands., Wegmann F; Janssen Vaccines & Prevention, Leiden, The Netherlands., Zahn RC; Janssen Vaccines & Prevention, Leiden, The Netherlands., Schuitemaker H; Janssen Vaccines & Prevention, Leiden, The Netherlands., Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. dbarouch@bidmc.harvard.edu.; Harvard Medical School, Boston, MA, USA. dbarouch@bidmc.harvard.edu.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA. dbarouch@bidmc.harvard.edu.; Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA. dbarouch@bidmc.harvard.edu.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2022 Jan 10; Vol. 7 (1), pp. 2. Date of Electronic Publication: 2022 Jan 10.
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.
Autor:
Solforosi L; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Kuipers H; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Jongeneelen M; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Rosendahl Huber SK; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., van der Lubbe JEM; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Dekking L; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Czapska-Casey DN; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Izquierdo Gil A; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Baert MRM; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Drijver J; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Vaneman J; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., van Huizen E; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Choi Y; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Vreugdenhil J; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Kroos S; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., de Wilde AH; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Kourkouta E; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Custers J; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., van der Vlugt R; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Veldman D; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Huizingh J; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Kaszas K; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Dalebout TJ; Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands., Myeni SK; Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands., Kikkert M; Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands., Snijder EJ; Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands., Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Böszörményi KP; Biomedical Primate Research Centre, Rijswijk, Netherlands., Stammes MA; Biomedical Primate Research Centre, Rijswijk, Netherlands., Kondova I; Biomedical Primate Research Centre, Rijswijk, Netherlands., Verschoor EJ; Biomedical Primate Research Centre, Rijswijk, Netherlands., Verstrepen BE; Biomedical Primate Research Centre, Rijswijk, Netherlands., Koopman G; Biomedical Primate Research Centre, Rijswijk, Netherlands., Mooij P; Biomedical Primate Research Centre, Rijswijk, Netherlands., Bogers WMJM; Biomedical Primate Research Centre, Rijswijk, Netherlands., van Heerden M; Non-Clinical Safety Toxicology/Pathology, Janssen Research and Development, Beerse, Belgium., Muchene L; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Tolboom JTBM; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Roozendaal R; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Brandenburg B; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Schuitemaker H; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Wegmann F; Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Zahn RC; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2021 Jul 05; Vol. 218 (7).
Autor:
van der Lubbe JEM; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands. Jvander7@its.jnj.com., Rosendahl Huber SK; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Vijayan A; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Dekking L; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., van Huizen E; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Vreugdenhil J; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Choi Y; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Baert MRM; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Feddes-de Boer K; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Izquierdo Gil A; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., van Heerden M; Janssen Non-Clinical Safety B.V., Beerse, Belgium., Dalebout TJ; Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands., Myeni SK; Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands., Kikkert M; Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands., Snijder EJ; Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands., de Waal L; Viroclinics Biosciences B.V., Viroclinics Xplore, Schaijk, The Netherlands., Stittelaar KJ; Wageningen Bioveterinary Research, Lelystad, The Netherlands., Tolboom JTBM; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Serroyen J; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Muchene L; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., van der Fits L; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Rutten L; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Langedijk JPM; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Schuitemaker H; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Zahn RC; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Wegmann F; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2021 Mar 19; Vol. 6 (1), pp. 39. Date of Electronic Publication: 2021 Mar 19.